• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Pfizer (NY:PFE)

    24.25 +0.20 (+0.83%)
    Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Pfizer

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    Why AstraZeneca Crashed 8%, Leading Three Rivals, Including Pfizer, To Jump ↗
    AstraZeneca stock crashed Thursday after its Ionis-partnered treatment for a rare heart disease failed in Phase 3 testing. 
    Via Investor's Business Daily
    News headline image
    2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now ↗
    They may not remain cheap for too much longer. 
    Via The Motley Fool
    Topics Intellectual Property
    These S&P500 stocks are the most active in today's session ↗
    Via Chartmill
    News headline image
    Opinion: Pfizer's Dividend Is Riskier Than You Might Think ↗
    A 7% dividend yield will grab your attention, but be sure to read the fine print. 
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Hospira Brand Bacteriostatic Water: Uses, Safety, and Clinical Guidelines ↗
    Hospira brand bacteriostatic water is a sterile, non-pyrogenic preparation of water for injection that contains 0.9 
    Via Talk Markets
    News headline image
    Pfizer's Growth Story Faces a Wait as Pipeline and Leadership Doubts Mount ↗
    Pfizer was downgraded to Hold as analysts cited delayed pipeline catalysts, management changes and reduced near-term re-rating potential. 
    Via Benzinga
    Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗
    Via Chartmill
    News headline image
    Meet the 4 S&P 500 Dividend Stocks That Yield at Least 6%. Here's My Strongest Buy of the Bunch in July. ↗
    One stands above the others. 
    Via The Motley Fool
    Topics Stocks
    News headline image
    Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant ↗
    Could this be the secret to Pfizer's rebound strategy? 
    Via The Motley Fool
    News headline image
    OS Therapies Appoints Dr. Craig Eagle to Board of Directors
    Company secures $10 million line of credit supported by OS Therapies UK tax creditsNew York, New York and Rockville, Maryland--(Newsfile... 
    Via Newsfile
    News headline image
    Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right. ↗
    Analysts have given Alnylam Pharmaceuticals an average price target of $436. 
    Via The Motley Fool
    News headline image
    2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down
    Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
    Via StockStory
    News headline image
    Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy? ↗
    These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals. 
    Via The Motley Fool
    News headline image
    Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest
    Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Zoetis (NYSE:ZTS) and its pee... 
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    The Fine Print Most Canadians Miss When Holding U.S. Stocks in a TFSA ↗
    Maximize your investment opportunities in US stocks with a TFSA while being aware of the tax implications of dividends. 
    Via The Motley Fool
    Topics Artificial Intelligence ETFs Retirement
    Looking for the most active stocks in the S&P500 index on Tuesday? ↗
    Via Chartmill
    News headline image
    Why Pfizer Could Prove to Be an Underrated GLP-1 Stock ↗
    It could prove to be a case of better later than never for the healthcare giant. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Big Pharma Has a Case of Merger Mania ↗
    Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and clinical-stage candidates to bolster the development pipeline. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Nike Just Hit an 11-Year Low. Will Its Turnaround Finally Start on Wednesday? ↗
    Nike is set to report earnings on June 30. Here's what to expect. 
    Via The Motley Fool
    Topics World Trade
    News headline image
    3 No-Brainer Dividend Stocks to Buy Right Now ↗
    AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More ↗
    Why settle for puny yields when you can buy these monster dividend stocks? 
    Via The Motley Fool
    Topics ETFs Energy
    News headline image
    A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock? ↗
    Things are going from bad to worse for the pharmaceutical giant. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now ↗
    Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    The Market Just Pulled Back Again. These 3 Blue Chips Are the Ones to Buy. ↗
    Take advantage of short-term weakness by stepping into the right long-term investments when they go on sale. 
    Via The Motley Fool
    Topics Artificial Intelligence Credit Cards Earnings
    News headline image
    Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly Dividends ↗
    The sizable yield comes with a concerning footnote. Just look at the rest of the story. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Alphabet Is Joining the Dow Jones Industrial Average. 3 Surprising Reasons Why SpaceX Could Be Next. ↗
    With just 30 components, the Dow's exclusivity is built on industry leadership, which SpaceX has in spades. 
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    News headline image
    AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026? ↗
    AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics. 
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right? ↗
    Novo Nordisk is no longer the front-runner, but it's not out of the running, either. 
    Via The Motley Fool
    News headline image
    FDA Expands Pfizer's Ibrance Label For Frontline Maintenance In Advanced Breast Cancer ↗
    The FDA approves Pfizer's Ibrance regimen for HR+, HER2+ metastatic breast cancer maintenance after positive Phase 3 data. 
    Via Benzinga
    News headline image
    2 Large-Cap Stocks to Target This Week and 1 We Find Risky
    Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.